Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Journal of Neuroinflammation|July 22, 2019
The retinal environment induces microglia-like properties in recruited myeloid cellsScott W McPherson, Neal D Heuss, Ute Lehmann, et al.Diabetes Technology & Therapeutics|July 10, 2010
Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim studyAndreas Pfützner, Michael Derwahl, Stephan Jacob, et al.Diabetes Technology & Therapeutics|April 5, 2011
PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemiaAndreas Pfützner, Thomas Schöndorf, Diethelm Tschöpe, et al.Journal of Diabetes Science and Technology|April 30, 2011
The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix studyThomas Schöndorf, Petra B Musholt, Cloth Hohberg, et al.Clinical Science (London, England : 1979)|June 1, 2010
Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitusThomas Forst, Matthias M Weber, Mirjam Löbig, et al.Diabetes & Vascular Disease Research|October 30, 2008
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular riskThomas Forst, Birgit Wilhelm, Andreas Pfützner, et al.Cellular Signalling|February 3, 2005
The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signallingThomas Clahsen, Ute Lehmann, Claudia Stross, et al.Cellular Signalling|June 2, 2005
Determinants governing the potency of STAT3 activation via the individual STAT3-recruiting motifs of gp130Ute Lehmann, Ulrike Sommer, Tanya Smyczek, et al.The Journal of Biological Chemistry|July 8, 2005
Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinasesUlrike Sommer, Christine Schmid, Radoslaw M Sobota, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE studyPeter Schmid, Michael Untch, Valentin Kossé, et al.Pageof 3